Literature DB >> 23009912

Computed tomography and cardiac magnetic resonance imaging in pulmonary hypertension.

Gerin R Stevens1, Nadia Fida, Javier Sanz.   

Abstract

Recent advances in imaging technology have allowed for better temporal and spatial resolution in cardiovascular imaging. The idea of a "one-stop shop" for anatomical and functional cardiopulmonary and vascular assessment in patients with pulmonary hypertension is very appealing since diagnostic, prognostic, and therapeutic response can be measured. Modalities, such as computed tomography (CT) and cardiac magnetic resonance (CMR), are better suited to image the right heart and associated structures in multiple projections allowing for three-dimensional data sets and image reconstruction. This review will focus on the use of CT and CMR in the assessment of the right ventricle and pulmonary structures as they relate to pulmonary vascular disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23009912     DOI: 10.1016/j.pcad.2012.07.009

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  7 in total

1.  Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study.

Authors:  Michael Pienn; Gabor Kovacs; Maria Tscherner; Alexander Avian; Thorsten R Johnson; Peter Kullnig; Rudolf Stollberger; Andrea Olschewski; Horst Olschewski; Zoltán Bálint
Journal:  Eur Radiol       Date:  2013-12-06       Impact factor: 5.315

2.  CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.

Authors:  Anand S Iyer; J Michael Wells; Sonia Vishin; Surya P Bhatt; Keith M Wille; Mark T Dransfield
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

3.  Flow characteristics of the proximal pulmonary arteries and vena cava in patients with chronic thromboembolic pulmonary hypertension: correlation between 3.0 T phase-contrast MRI and right heart catheterization.

Authors:  Xiaojuan Guo; Min Liu; Zhanhong Ma; Shuangkun Wang; Yuanhua Yang; Zhenguo Zhai; Chen Wang; Renyou Zhai
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

Review 4.  A GPS map for pulmonary hypertension: a review of imaging modalities.

Authors:  Jinghui Li; Ashley Lee; Yingsheng Cheng
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

5.  Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.

Authors:  Mohamad Amer Alaiti; Aditya Goud; Gautam Ramani; Sashwatee Bagchi; Sadeer Al-Kindi; Steven Sawicki; Christopher Longenecker; Trevor Jenkins; David Pauza; Myung Park; Grace McComsey; Orlando Simonetti; Brian Hoit; Sanjay Rajagopalan
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-11       Impact factor: 2.160

6.  Use of computed tomography and automated software for quantitative analysis of the vasculature of patients with pulmonary hypertension.

Authors:  Danilo Tadao Wada; Adriana Ignácio de Pádua; Moyses Oliveira Lima Filho; José Antonio Marin Neto; Jorge Elias Júnior; José Baddini-Martinez; Marcel Koenigkam Santos
Journal:  Radiol Bras       Date:  2017 Nov-Dec

7.  Quantification of tortuosity and fractal dimension of the lung vessels in pulmonary hypertension patients.

Authors:  Michael Helmberger; Michael Pienn; Martin Urschler; Peter Kullnig; Rudolf Stollberger; Gabor Kovacs; Andrea Olschewski; Horst Olschewski; Zoltán Bálint
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.